Everomime™
Everolimus-eluting coronary stent system

Everomime™

Drug-Eluting Stents · Everolimus-eluting stents

Everomime™

Everomime is Kepler’s everolimus-eluting coronary stent system, built around an ultra-thin 50 µm cobalt-chromium (L605) scaffold. The thinner strut profile is intended to reduce the amount of metal placed against the vessel wall while the hybrid-cell geometry maintains scaffolding across the treated segment.

Everolimus is carried on a biodegradable and biocompatible PLLA + PLGA polymer applied as a thin 2 µm coating. The stent is pre-mounted on a monolithic rapid-exchange delivery system with a reinforced hypotube and an elongated distal tip, designed for pushability and lesion entry in tortuous coronary anatomy.

Key features.

Product highlights.

  • Stent design: Hybrid cell design
  • Stent material: Cobalt chromium L605
  • Strut thickness: 50 µm
  • Stent diameters: 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00, 4.50 mm
  • Stent lengths: 8, 13, 16, 19, 24, 29, 32, 37, 40, 44, 48 mm
  • Mean recoil / length change: < 4 % / < 1.0 %
  • Drug: Everolimus

Design & technology.

How Everomime™ is built and what each part of the system does.

Product design & architecture

The scaffold combines open and closed cells in a hybrid pattern. Y-connectors and S-links join adjacent rings, and the strut width varies along each ring to concentrate material where radial support is required.

  • Hybrid cell design (open + closed cells)
  • Y-connector and S-link interconnections
  • Strut-width variability along each ring
  • Mean recoil < 4 % and length change < 1.0 %

Stent technology

Cobalt-chromium L605 allows a thin strut while retaining radiopacity and radial strength. At 50 µm, Everomime’s struts are 15 µm thinner than the 65 µm sirolimus platforms in the range.

  • Material: cobalt chromium L605
  • Strut thickness: 50 µm
  • Diameters 2.00–4.50 mm; lengths 8–48 mm

Drug & polymer technology

Everolimus, a limus-family antiproliferative, is released from a biodegradable PLLA + PLGA polymer. The coating is 2 µm thick.

  • Drug: everolimus
  • Dose: 1.25 µg/mm² of stent surface
  • Polymer: PLLA + PLGA, biodegradable and biocompatible
  • Coating thickness: 2 µm

Delivery system

A monolithic rapid-exchange catheter with a reinforced hypotube transmits push from hub to tip. A 7 mm elongated distal tip with a 0.016" entry profile acts like a micro-catheter for lesion entry.

  • Rapid exchange, 142 cm usable length
  • Nominal 8 atm; rated burst 14/16 atm depending on stent size and length
  • Balloon overhang ≤ 0.5 mm; two Pt/Ir markers
  • 5 F guide compatible; 0.014" guidewire
Delivery-system and tip architecture
Delivery-system and tip architecture

Intended applications.

  • Catheter-based treatment of selected coronary stenoses
  • Coronary scaffold placement following lesion assessment and preparation

Device-use information.

Everomime is intended for improving coronary luminal diameter in patients with symptomatic ischaemic heart disease due to de novo and restenotic lesions in native coronary arteries.

Read the instructions for use supplied with the device for contraindications, warnings, precautions and handling instructions.

Request instructions for use
Healthcare and medical technology editorial visual

Product details.

Product brochure

Everomime e-catalogue

Download the Everomime™ e-catalogue for the product description, key features, design and technology, technical specifications and the full ordering information with ordering codes.

The PDF preview loads when this tab opens. If your browser cannot display PDFs inline, use Open in new tab or Download PDF.

Technical information & ordering.

Product and ordering summary
InformationEveromime™
ProductEveromime™
Device typeEverolimus-eluting coronary stent system
CategoryDrug-Eluting Stents — Everolimus-eluting stents
Available configurations87 — see the Size Chart tab for ordering codes
Technical specificationsSee the Specification tab
E-catalogueAvailable in the View Brochure tab
SupplyPre-mounted on its rapid-exchange delivery system, sterile and for single use

To order, quote the product name and the ordering code from the Size Chart.

Product FAQ.

What is Everomime™ used for?

Everomime is intended for improving coronary luminal diameter in patients with symptomatic ischaemic heart disease due to de novo and restenotic lesions in native coronary arteries.

Which sizes does Everomime™ come in?

Everomime™ is available in 87 configurations (stent diameters: 2.00, 2.25, 2.50, 2.75, 3.00, 3.50, 4.00, 4.50 mm; stent lengths: 8, 13, 16, 19, 24, 29, 32, 37, 40, 44, 48 mm; mean recoil / length change: < 4 % / < 1.0 %). The Size Chart tab lists every size with its ordering code.

What is Everomime™ made of?

Cobalt chromium L605. The Specification tab gives the full list of materials and dimensions.

How is Everomime™ supplied?

Everomime™ is supplied pre-mounted on its rapid-exchange delivery system, sterile and for single use. Read the instructions for use packed with the device before use.

How do I order Everomime™?

Send an enquiry from this page with the product name and the ordering code from the Size Chart. The Kepler team will respond with availability and pricing.

Connect with Kepler about Everomime™.

Connect with Kepler for product, documentation and business enquiries.

Stay connected. Stay informed.

Request product and company updates from Kepler.

Expanded product visual